The investment will be made across the value chain, from drug discovery and clinical development to production.

The company says the proposal will create space for hundreds of its staff to work at the campus.

AstraZeneca is moving ahead with a major build-out of its American footprint, tying a new facility to a broader $3.5 billion push in research and manufacturing across the United States. The company ...

AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to ...

AstraZeneca’s investment will “span the value chain” of drug research and development and comes amid a prolonged surge in ...

The drug maker says the funding will expand medicines production and research capabilities, as London and Beijing seek to ...

UK-Swedish drugmaker AstraZeneca plans to invest USD15 billion in China over the next five years to expand its drug ...

AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobs New manufacturing facility to be located near Charlottesville, in ...

Fourth major US manufacturing investment announced this year, advancing AstraZeneca’s historic $50 billion commitment to medicines manufacturing and R&D The Frederick facility currently produces ...

Add Yahoo as a preferred source to see more of our stories on Google. AstraZeneca could build a new six-storey block at Cambridge Biomedical Campus (CBC) to house offices and a conference centre. The ...